  Interleukin Genetics   –  Interleukin Genetics Appoints Mark B. Carbeau as CEO                             Interleukin Genetics Appoints Mark B. Carbeau as CEO Interleukin Genetics Appoints Mark B. Carbeau as CEOWALTHAM, MA, April 7, 2015 – Interleukin Genetics, Inc. (OTCQB: ILIU) today announced the appointment of Mark B. Carbeau as Chief Executive Officer and Director.  Dr. Kenneth S. Kornman, DDS, PhD, who served as the President and CEO since August 2012, will continue to serve as President, Chief Scientific Officer and a Director.Mr. Carbeau is a transformative healthcare leader who brings to Interleukin more than three decades of business expertise in the life science industries, with a proven track record of building high growth diagnostic and pharmaceutical businesses.  Recognized as a visionary entrepreneur, Mr. Carbeau has refined or reinvented corporate strategies and business models to maximize the growth potential of multiple companies.  His appointment strengthens the executive leadership team and adds significant commercial and operational expertise.“On behalf of the Board of Directors of Interleukin Genetics, I am excited to welcome Mark Carbeau to the Company,” said James M. Weaver, Chairman of The Board of Interleukin Genetics.  “Mark is a leader with an outstanding track record of building high growth healthcare businesses, including taking multiple products from ideation to commercialization and category leadership.  I am confident that under Mark’s leadership the Company will continue to grow and create value for our partners and shareholders.”Mr. Weaver continued, “I would like to thank Ken for his years of service in the roles of President and CEO.  As one of the founders and Chief Scientific Officer of Interleukin, Ken has made many outstanding contributions to the Company, and has been an outspoken proponent of personalized medicine and an industry leader in the research, development and commercialization of genetics-based risk assessment products and services to improve healthcare. We look forward to benefiting from his continued scientific leadership.”“I welcome the opportunity to lead Interleukin Genetics during this exciting time as we work toward our goal of providing more personalized care for the prevention of periodontal disease and other major human diseases,” said Mr. Carbeau.  “I also look forward to working with the senior management team, all Interleukin colleagues and our provider partners to achieve our collective goal of improving patients’ lives.”Prior to joining Interleukin, Mr. Carbeau was Co-Founder and CEO of Diagnostyx, a technology-based healthcare company focused on intelligent drug infusion systems. Prior to Diagnostyx, Mr. Carbeau served as CEO of PolyRemedy®, a technology-enabled services business that combines health information technology with personalized therapeutics to improve wound healing outcomes.Previously, Mr. Carbeau was the President and CEO of HyperMed, Inc., a commercial stage medical device and diagnostics company using novel hyperspectral imaging technology. Prior to HyperMed, Mr. Carbeau served as President USA of Kinetic Concepts, Inc., and successfully reinvigorated the business by growing revenues from $650 million to $950 million.  Prior to that, Mr. Carbeau served as Vice President, Corporate Development at OraPharma, Inc., during its commercial launch of a periodontal therapeutic, a successful IPO, and the eventual sale of the company to Johnson & Johnson.  Mr. Carbeau also founded CM Partners, a strategic life science consulting firm, and was a member of The Boston Consulting Group.  Mr. Carbeau began his career serving in various sales, marketing and manufacturing roles with Eli Lilly and Company.  He holds a B.S. in Industrial Engineering from Pennsylvania State University and an M.B.A. from the Wharton School of the University of Pennsylvania. About Interleukin Genetics Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets proprietary genetic tests for chronic diseases and health related conditions. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its research, intellectual property and genetic panel development expertise in metabolism and inflammation to facilitate the emerging personalized healthcare market. The Company markets its tests through partnerships with health and wellness companies, healthcare professionals and other distribution channels. Interleukin Genetics’ lead products include its proprietary PerioPredict® genetic risk panel for periodontal disease and tooth loss susceptibility available through dentists, and the Inherent Health® Weight Management Genetic Test that identifies the most effective diet program for an individual based on genetics. Interleukin Genetics is headquartered in Waltham, MA and operates an on-site, state-of-the-art DNA testing laboratory certified under the Clinical Laboratories Improvements Amendments (CLIA). For more information, please visit 52.2.148.42.  Forward-Looking StatementsCertain statements contained herein are “forward-looking” statements, including statements that under Mr. Carbeau’s leadership the Company will continue to grow and create value for its partners and shareholders. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements.  Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those risks and uncertainties described in the Company’s annual report on Form 10-K for the year ended December 31, 2014, and other filings with the Securities and Exchange Commission. The Company disclaims any obligation or intention to update these forward-looking statements. MEDIA CONTACT:Eliza SchleifsteinArgot Partners(917) 763-8106eliza@argotpartners.com INVESTOR CONTACTS:Susie KimArgot Partners(212) 600-1902susan@argotpartners.com  Share This                Mark Carbeau | Interleukin Genetics , Inc. | ZoomInfo.com




Interleukin Genetics Appoints Mark B. Carbeau as CEO - News - dentalaegis.com






















































Inside Dentistry
Compendium
Inside Dental Technology
CDEWorld
SUBSCRIBE















Menu





News
Archives
Subscribe
Continuing Education
Products
Store
About Us
Contact Us









Interleukin Genetics Appoints Mark B. Carbeau as CEO
Posted on April  9, 2015

 Waltham, Mass. -- April 7, 2015 – Interleukin Genetics, Inc. (OTCQB: ILIU) today announced the appointment of Mark B. Carbeau as Chief Executive Officer and Director. Dr. Kenneth S. Kornman, DDS, PhD, who served as the President and CEO since August 2012, will continue to serve as President, Chief Scientific Officer and a Director.

	Mr. Carbeau is a transformative healthcare leader who brings to Interleukin more than three decades of business expertise in the life science industries, with a proven track record of building high growth diagnostic and pharmaceutical businesses. Recognized as a visionary entrepreneur, Mr. Carbeau has refined or reinvented corporate strategies and business models to maximize the growth potential of multiple companies. His appointment strengthens the executive leadership team and adds significant commercial and operational expertise.
	“On behalf of the Board of Directors of Interleukin Genetics, I am excited to welcome Mark Carbeau to the Company,” said James M. Weaver, Chairman of The Board of Interleukin Genetics. “Mark is a leader with an outstanding track record of building high growth healthcare businesses, including taking multiple products from ideation to commercialization and category leadership. I am confident that under Mark’s leadership the Company will continue to grow and create value for our partners and shareholders.”

	Mr. Weaver continued, “I would like to thank Ken for his years of service in the roles of President and CEO. As one of the founders and Chief Scientific Officer of Interleukin, Ken has made many outstanding contributions to the Company, and has been an outspoken proponent of personalized medicine and an industry leader in the research, development and commercialization of genetics-based risk assessment products and services to improve healthcare. We look forward to benefiting from his continued scientific leadership.”

	“I welcome the opportunity to lead Interleukin Genetics during this exciting time as we work toward our goal of providing more personalized care for the prevention of periodontal disease and other major human diseases,” said Mr. Carbeau. “I also look forward to working with the senior management team, all Interleukin colleagues and our provider partners to achieve our collective goal of improving patients’ lives.”
	Prior to joining Interleukin, Mr. Carbeau was Co-Founder and CEO of Diagnostyx, a technology-based healthcare company focused on intelligent drug infusion systems. Prior to Diagnostyx, Mr. Carbeau served as CEO of PolyRemedy®, a technology-enabled services business that combines health information technology with personalized therapeutics to improve wound healing outcomes.

	Previously, Mr. Carbeau was the President and CEO of HyperMed, Inc., a commercial stage medical device and diagnostics company using novel hyperspectral imaging technology. Prior to HyperMed, Mr. Carbeau served as President USA of Kinetic Concepts, Inc., and successfully reinvigorated the business by growing revenues from $650 million to $950 million. Prior to that, Mr. Carbeau served as Vice President, Corporate Development at OraPharma, Inc., during its commercial launch of a periodontal therapeutic, a successful IPO, and the eventual sale of the company to Johnson & Johnson. Mr. Carbeau also founded CM Partners, a strategic life science consulting firm, and was a member of The Boston Consulting Group. Mr. Carbeau began his career serving in various sales, marketing and manufacturing roles with Eli Lilly and Company. He holds a B.S. in Industrial Engineering from Pennsylvania State University and an M.B.A. from the Wharton School of the University of Pennsylvania.

 About Interleukin Genetics
	Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets proprietary genetic tests for chronic diseases and health related conditions. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its research, intellectual property and genetic panel development expertise in metabolism and inflammation to facilitate the emerging personalized healthcare market. The Company markets its tests through partnerships with health and wellness companies, healthcare professionals and other distribution channels. Interleukin Genetics’ lead products include its proprietary PerioPredict® genetic risk panel for periodontal disease and tooth loss susceptibility available through dentists, and the Inherent Health® Weight Management Genetic Test that identifies the most effective diet program for an individual based on genetics. Interleukin Genetics is headquartered in Waltham, MA and operates an on-site, state-of-the-art DNA testing laboratory certified under the Clinical Laboratories Improvements Amendments (CLIA). For more information, please visit www.ilgenetics.com.

 Forward-Looking Statements
	Certain statements contained herein are “forward-looking” statements, including statements that under Mr. Carbeau’s leadership the Company will continue to grow and create value for its partners and shareholders. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those risks and uncertainties described in the Company’s annual report on Form 10-K for the year ended December 31, 2014, and other filings with the Securities and Exchange Commission. The Company disclaims any obligation or intention to update these forward-looking statements.



Recent Headlines


Ron Appel and Jeremy Ross Participated in UPS’ Women’s Business Resource Group 10th Anniversary Meeting
July 24, 2017


Smart Training: Low-Cost ‘Essentials’ Compliance Package
July 24, 2017


Cold as Ice Endo Spray by Dental Creations, LTD
July 21, 2017


 ClearCorrect new Flex and Unlimited pricing 
July 21, 2017


Forward Science Recognized for Enhancing the Positive Image of Small Businesses
July 21, 2017



Older Posts

Most Recent

2017

July
June
May
April
March
February
January



2016

December
November
October
September
August
July
June
May
April
March
February
January



2015

December
November
October
September
August
July
June
May
April
March
February
January



2014

December
November
October
September
August
July
June
May
April
March
February
January



2013

December
November
October









				Stay up to date with 
									us!
			







CE
Subscribe
Archive
News
Products




View All of Our Brands
Inside Dentistry
Compendium
Inside Dental Technology
CDE World




Contact Us
About Us
Advertisers
Creative Services






			© 2017 AEGIS Communications | Privacy Policy















Interleukin Genetics Appoints Mark B. Carbeau As CEO - TheStreet




































































 

 




















Action Alerts PLUS

Access AAPJim Cramer's Best Stocks for 2017Charitable Trust PortfolioMost Recent Trade Alert25 Investing Rules10 Trading Commandments

Real Money

Access RM25 Rules of InvestingJim Cramer's Best Stocks for 201710 CommandmentsStressed Out StocksCramer's Blog

Cramer
Mad Money
ETFs
Futures
Markets
Much More

BanksBiotechRetailTechPersonal FinanceRetirementFinancial Advisor CenterHow to SpendOptionsFixed IncomeVideo










Privacy Policy|Terms of Use© 1996- TheStreet Inc. All rights reserved
















                                DJIA
                            







                                NASDAQ
                            







                                S&P 500
                            






Market Data updated






Sign In




Your Membership(s)








Your Account





Account Preferences


Alerts


Newsletters







Subscribe





Logout



Subscribe

Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Action Alerts PLUS
Action Alerts OPTIONS
Daily Swing Trade
Income Seeker
Quant Ratings
Real Money
Real Money Pro
Stocks Under $10
Top Stocks
Trifecta Stocks
Real Money Pro Portfolio
Chairman's Club
Compare All 
Chatter on the Street













































 








































Interleukin Genetics Appoints Mark B. Carbeau As CEO






Business Wire




Apr 7, 2015 8:00 AM EDT













 




























































  Interleukin Genetics, Inc. (OTCQB:ILIU) today announced the appointment of Mark B. Carbeau as Chief Executive Officer and Director. Dr. Kenneth S. Kornman, DDS, PhD, who served as the President and CEO since August 2012, will continue to serve as President, Chief Scientific Officer and a Director.  Mr. Carbeau is a transformative healthcare leader who brings to Interleukin more than three decades of business expertise in the life science industries, with a proven track record of building high growth diagnostic and pharmaceutical businesses. Recognized as a visionary entrepreneur, Mr. Carbeau has refined or reinvented corporate strategies and business models to maximize the growth potential of multiple companies. His appointment strengthens the executive leadership team and adds significant commercial and operational expertise.  "On behalf of the Board of Directors of Interleukin Genetics, I am excited to welcome Mark Carbeau to the Company," said James M. Weaver, Chairman of The Board of Interleukin Genetics. "Mark is a leader with an outstanding track record of building high growth healthcare businesses, including taking multiple products from ideation to commercialization and category leadership. I am confident that under Mark's leadership the Company will continue to grow and create value for our partners and shareholders."  Mr. Weaver continued, "I would like to thank Ken for his years of service in the roles of President and CEO. As one of the founders and Chief Scientific Officer of Interleukin, Ken has made many outstanding contributions to the Company, and has been an outspoken proponent of personalized medicine and an industry leader in the research, development and commercialization of genetics-based risk assessment products and services to improve healthcare. We look forward to benefiting from his continued scientific leadership."  "I welcome the opportunity to lead Interleukin Genetics during this exciting time as we work toward our goal of providing more personalized care for the prevention of periodontal disease and other major human diseases," said Mr. Carbeau. "I also look forward to working with the senior management team, all Interleukin colleagues and our provider partners to achieve our collective goal of improving patients' lives."  



 








 































































 











Trending


Walmart in Focus Amid 'Horrific' Human Trafficking Incident in Texas That Causes Nine Deaths


We Must All Stop Blindly Trusting in the Apple iPhone - It Could Also Be Viciously Hacked


10 Stocks to Give as Gifts


FTC Seen as Set to Block Rite Aid Deal


Earnings Are Back With a Vengeance: Cramer's 'Mad Money' Recap (Monday 7/24/17)











Advertising Partners



 






 






 






 


























 

























 































 


©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.




Compare Brokers



 







 







 







 







 







 












 



Interleukin Genetics Appoints Mark B. Carbeau as CEO | Business Wire


























































Interleukin Genetics Appoints Mark B. Carbeau as CEO






April 07, 2015 08:00 AM Eastern Daylight Time



WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today announced the appointment 
      of Mark B. Carbeau as Chief Executive Officer and Director. Dr. Kenneth 
      S. Kornman, DDS, PhD, who served as the President and CEO since August 
      2012, will continue to serve as President, Chief Scientific Officer and 
      a Director.
    


      Mr. Carbeau is a transformative healthcare leader who brings to 
      Interleukin more than three decades of business expertise in the life 
      science industries, with a proven track record of building high growth 
      diagnostic and pharmaceutical businesses. Recognized as a visionary 
      entrepreneur, Mr. Carbeau has refined or reinvented corporate strategies 
      and business models to maximize the growth potential of multiple 
      companies. His appointment strengthens the executive leadership team and 
      adds significant commercial and operational expertise.
    

      “On behalf of the Board of Directors of Interleukin Genetics, I am 
      excited to welcome Mark Carbeau to the Company,” said James M. Weaver, 
      Chairman of The Board of Interleukin Genetics. “Mark is a leader with an 
      outstanding track record of building high growth healthcare businesses, 
      including taking multiple products from ideation to commercialization 
      and category leadership. I am confident that under Mark’s leadership the 
      Company will continue to grow and create value for our partners and 
      shareholders.”
    

      Mr. Weaver continued, “I would like to thank Ken for his years of 
      service in the roles of President and CEO. As one of the founders and 
      Chief Scientific Officer of Interleukin, Ken has made many outstanding 
      contributions to the Company, and has been an outspoken proponent of 
      personalized medicine and an industry leader in the research, 
      development and commercialization of genetics-based risk assessment 
      products and services to improve healthcare. We look forward to 
      benefiting from his continued scientific leadership.”
    

      “I welcome the opportunity to lead Interleukin Genetics during this 
      exciting time as we work toward our goal of providing more personalized 
      care for the prevention of periodontal disease and other major human 
      diseases,” said Mr. Carbeau. “I also look forward to working with the 
      senior management team, all Interleukin colleagues and our provider 
      partners to achieve our collective goal of improving patients’ lives.”
    

      Prior to joining Interleukin, Mr. Carbeau was Co-Founder and CEO of 
      Diagnostyx, a technology-based healthcare company focused on intelligent 
      drug infusion systems. Prior to Diagnostyx, Mr. Carbeau served as CEO of 
      PolyRemedy®, a technology-enabled services business that combines health 
      information technology with personalized therapeutics to improve wound 
      healing outcomes.
    

      Previously, Mr. Carbeau was the President and CEO of HyperMed, Inc., a 
      commercial stage medical device and diagnostics company using novel 
      hyperspectral imaging technology. Prior to HyperMed, Mr. Carbeau served 
      as President USA of Kinetic Concepts, Inc., and successfully 
      reinvigorated the business by growing revenues from $650 million to $950 
      million. Prior to that, Mr. Carbeau served as Vice President, Corporate 
      Development at OraPharma, Inc., during its commercial launch of a 
      periodontal therapeutic, a successful IPO, and the eventual sale of the 
      company to Johnson & Johnson. Mr. Carbeau also founded CM Partners, a 
      strategic life science consulting firm, and was a member of The Boston 
      Consulting Group. Mr. Carbeau began his career serving in various sales, 
      marketing and manufacturing roles with Eli Lilly and Company. He holds a 
      B.S. in Industrial Engineering from Pennsylvania State University and an 
      M.B.A. from the Wharton School of the University of Pennsylvania.
    

About Interleukin Genetics


      Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets 
      proprietary genetic tests for chronic diseases and health related 
      conditions. The products empower individuals to prevent certain chronic 
      conditions and manage their existing health and wellness through 
      genetic-based insights with actionable guidance. Interleukin Genetics 
      leverages its research, intellectual property and genetic panel 
      development expertise in metabolism and inflammation to facilitate the 
      emerging personalized healthcare market. The Company markets its tests 
      through partnerships with health and wellness companies, healthcare 
      professionals and other distribution channels. Interleukin Genetics’ 
      lead products include its proprietary PerioPredict® genetic risk panel 
      for periodontal disease and tooth loss susceptibility available through 
      dentists, and the Inherent Health® Weight Management Genetic Test that 
      identifies the most effective diet program for an individual based on 
      genetics. Interleukin Genetics is headquartered in Waltham, MA and 
      operates an on-site, state-of-the-art DNA testing laboratory certified 
      under the Clinical Laboratories Improvements Amendments (CLIA). For more 
      information, please visit www.ilgenetics.com.
    

Forward-Looking Statements


      Certain statements contained herein are “forward-looking” statements, 
      including statements that under Mr. Carbeau’s leadership the Company 
      will continue to grow and create value for its partners and 
      shareholders. Because such statements include risks and uncertainties, 
      actual results may differ materially from those expressed or implied by 
      such forward-looking statements. Factors that could cause actual results 
      to differ materially from those expressed or implied by such 
      forward-looking statements include, but are not limited to, those risks 
      and uncertainties described in the Company’s annual report on Form 10-K 
      for the year ended December 31, 2014, and other filings with the 
      Securities and Exchange Commission. The Company disclaims any obligation 
      or intention to update these forward-looking statements.
    


Contacts

MEDIA:Argot PartnersEliza Schleifstein, 917-763-8106eliza@argotpartners.comorINVESTOR:Argot 
      PartnersMatthew Haines, 212-600-1902matthew@argotpartners.comorSusie 
      Kim, 212-600-1902susan@argotpartners.com













Contacts

MEDIA:Argot PartnersEliza Schleifstein, 917-763-8106eliza@argotpartners.comorINVESTOR:Argot 
      PartnersMatthew Haines, 212-600-1902matthew@argotpartners.comorSusie 
      Kim, 212-600-1902susan@argotpartners.com







 
 

 






Search




Advanced News Search

Advanced News Search













Log In
Sign Up



















Mark Carbeau (B), 57  - Marblehead, MA | MyLife.com™ Background Profile



































Search for your public page


First Name



Last Name



City





Search


*All fields are required
Already a member? Log in


















About & Contact Info






                    Photos && Social Posts






Reviews & Ratings





Court & ArrestRecords





Friends & Family












 MC


View Photos



 Edit/Remove

Mark Carbeau
 Marblehead, MA
 Age: 57 -
								07/06/1960




AKA:
                                                Mark B Carbeau













Work Info








                                    Single






Has Kids







                                    Republican Party









Education Info





  Edit/Remove My Info

View Full Contact Info
- OR -
View Full Background Details







Reputation Score:
4.50/5




4.50

(2 Reviews)







                                        Rate:
                                        
                                            Mark










Improve my Rating
                                                |  
                                                 Ask others to Rate




Ranking: 
Compared to U.S. Population




BAD
POOR
FAIR
GOOD











  Edit/Remove My Info
Contact Info







View Phone Number










****@reunionemail.com

                                
                                     |  Send Message











6*** **** St


Marblehead, MA 01945







View Full Contact Details
- OR -
View Full Background Details








 + {{bingImagesInit.images.length - 4}} more
 + {{bingImagesInit.images.length - 3}} more



Summary:
                    
                        Mark Carbeau  was born in 1960.
        Mark
                   currently lives in 



Marblehead
.
        
                     Before that, he lived in
                        



Concord
, MA
                                          in 2008.
                                    















About & Contact Information


Mark's Story






Please Wait...


            Mark Carbeau  was born in 1960.
            Mark
                currently lives in 



Marblehead
.
            
                        Before that, he lived in
                        



Concord
, MA
                                        in 2008.
                                    

Views & Opinions

Pro-Choice Supporter






Contact Information





                            This section includes information on Addresses, Phone Numbers, and Email Addresses
                        




                                                Recent Address
                                            
6*** **** St
Marblehead, MA
View Address


Past Address
52*** **** Town




San Antonio
, TX
View Address


Past Address
17*** **** Rd




Chalfont
, PA
View Address


Past Address
21*** **** St




Cambridge
, MA
View Address


Past Address





Concord
, MA
View Address


Past Address





San Antonio
, TX
View Address


Past Address





Chalfont
, PA
View Address


Past Address





Cambridge
, MA
View Address




Email Address
****@reunionemail.com
View Email





    Mark may have hidden Social Profiles & Photos - Check Full Background Report to see Mark's social media activity. This may contain online profiles, dating websites, forgotten social media accounts, and other potentially embarrassing profiles. This may also contain additional contact information, giving you more ways to get in touch.
                




View Full Phone, Email & Address Details





Work History





    Mark may have Work information - Check Full Background Report to see possible job history including what current and previous jobs, companies they may have been employed at, job titles, duration of employment,  and a list of their co-workers.
                

                View Full Background Details
            





School History




    Mark may have Education Information - Check Full Background Report to see possible education history including where and when they attending high school and college, and a complete list of their high school class list.
                

                View Full Background Details
            





Properties




    Mark may have Properties - Check Full Background Report to see a complete list of known properties. This may contain information such as address, market value, purchase price,  and loan amount.


                View Full Background Details
            





Corporate Affiliations




    Mark may have Corporate Affiliations - Check Full Background Report to see a complete list of known corporate affiliations. This may contain information such as company name, job title, address, and time period of service.


                View Full Background Details
            





Licenses and Permits




    Mark may have Licenses & Permits - Check Full Background Report to see weapons permits, Federal Aviation Administration pilot licenses and Drug Enforcement Administration licenses for prescribing controlled pharmaceuticals. If applicable, you will also see Mark's license number and expiration date.
                

                View Full Background Details
            






Photos & Social Posts


Photos









ViewPhotos





    Mark may have Photos - Check Full Background Report to see possible pictures and photo albums found from social and public sources.
                

                View Full Background Details
            







Social Posts





View Social Posts



    We did not find any Social Posts records after searching multiple government records, social and public sources. As part of your premium service, we will continue to search and notify you when we find new information.



    Mark may have hidden Social Profiles & Photos - Check Full Background Report to see Mark's social media activity. This may contain online profiles, dating websites, forgotten social media accounts, and other potentially embarrassing profiles. This may also contain additional contact information, giving you more ways to get in touch.
                





Reviews & Ratings





Mark Carbeau's Reputation Score:
4.50/5



4.50

						        	
                                            (2 Reviews)
                                        







                                    Rate:
                                    
                                        Mark










Improve my Rating
                                            |  
                                             Ask others to Rate
                                            |  
                                            Write a Review




Ranking:  Compared to U.S. Population




BAD
POOR
FAIR
GOOD

















Anonymous


Personal Review
Posted on: 2017-04-20 06:46:29.0


i would be friends









Reply











Jeffrey Tinsley, CEO & Founder of Mylife.com

Personal Review









Reply










×
Showing balanced reviews improves the credibility of your positive reviews, so consider keeping them.Are you sure you want to delete this comment?
Yes
No








×
Your request has been sent.
Close









        Court & Arrest Records
        
            
            
                
            
        
    


Arrest and Criminal Records




    Mark may have Arrest and Criminal Records - Check Full Background Report to see possible arrest or conviction records we have found on Mark. This may include any DUIs, traffic tickets and outstanding warrants. When applicable, we may show where the crime occurred and provide details about the offense.


                View Full Background Details
            





Sex Offender Status




    Mark may have Sexual Offenses - Check Full Background Report to see a complete list of any and all sex offenses Mark may have been convicted of and his current sex offender status if applicable.
                

                View Full Background Details
            





Lawsuits, Liens & Bankruptcies




    Mark may have Lawsuits, Liens & Bankruptcies - Check Full Background Report to see local, state and federal court documents, sensitive legal information and any litigation that Mark may have been involved in.  We'll reveal arrest details like case numbers, offense descriptions, and booking dates, where available.
                

                View Full Background Details
            







Family & Friends


Relatives/Associates






 SC



                                                        ShirleyCarbeau


                                                      Ellwood City, PA



 BC



                                                        BernardCarbeau


                                                      Ellwood City, PA



 CC



                                                        CherylCarbeau


                                                      Concord, MA




                                    View More Relatives
                                





Classmates




    Mark may have a record of associated Classmates - Check Full Background Report to see possible who they are and full classlists  found from school records and public sources.
                

                View Full Background Details
            





Neighborhood Information | Information based on current address








Age








Education Level










Household Income








Estimated Home Values










Top Buying Habits








Top Interests & Hobbies



















A Full Background Report Includes



Find Background Profiles & Reputation Scores for Everyone in the U.S.



                            MyLife searches government, social & public sources to pull together all details in one place
                        




                            Contact details include addresses, email, phone numbers, photos & social profiles and more
                        




                            Background checks include arrest & court records, education & work history, personal reviews and more to asses anyone's reputation
                        



Only MyLife Helps You Improve Your Background Report & Reputation Score



                            Edit & correct your own Background Report to look your best to employers, clients, friends, dates & others searching for you on Google.
                        




                            Ask friends, family, employers & clients to review you to improve your public Reputation Score.
                        




                            Remove your information from sites you can't control to protect your privacy
                        



See What MyLife Customers Are Saying

                        "When considering new tenants, you should always
                        check and verify their background to feel secure
                        & protected. MyLife makes it easy"
                    


- Ron W.




 







Back to Top




















×
Send Message


Message sent
An error has occurred, please try again later...


How do you know this person?

Please select (used to notify recipient)
Unknown
College
High School
Junior High School
Grade School
Met on MyLife.com
Is My Friend
Related to Me
Mutual Friend
Work
Club or Organization
Religion Affiliation
Not Sure
Don't Know Them
Found You Through a Dating Service
Found Your Service



Subject



Message




 Add/Track Contact
							







SEND NOW

















×


					Your message has been sent.
				











×
Help Mark build his reputation & public image 
Thank you for rating Mark Carbeau
Please provide additional details to give people more insight into Mark's reputation. 



Sorry! We were unable to submit your review


                                        Please select at least one quality
                                    




Does Mark have these qualities?
Deselect all







Personal
Professional
Dating





 Smart
 Loyal
 Honest
 Good listener
 Humble
 Generous
 Fun
 Easy going
 Optimistic
 Kind
I would NOT be friends with Mark
 I would be friends

Is there anything you want to say about him on a personal level?
  (Optional)




 Responsible
 Hardworking
 Intelligent
 Collaborative
 Creative
 Resourceful
 Motivated
 Flexible
 Ambitious
 Articulate
I would NOT work with Mark

Is there anything you want to say about him on a professional level?
  (Optional)




 Faithful
 Respectful
 Understanding
 Funny
 Romantic
 Sexy
 Smart
 Passionate
 Good looking
 Good listener
 I would NOT date Mark

Is there anything you want to say about him concerning dating?
  (Optional)




You are responsible for your submissions, which must be true, lawful and not violate any person's rights. You agree to our User Agreement.







How do you know Mark?*

Friends
                                          Friend
Professional
Dating
Family Member
Neighbor
School
Club or Organization
Religious
Myself
Not Sure
Don't Know Them
Other







    Post anonymously
?






















































POST REVIEW








×

                        
                                Two Ways to Improve your Score
                            




Correct and Edit your extended background details
Correct & Edit


Ask Family & Friends  for positive reviews
  Send an Email
Share on Facebook










×





























×





Search to Find Background Reports & Publicly Exposed Personal Details on Anyone including Yourself.
Are You Mark Carbeau?


YES
See & control your exposed background info
See, Monitor & Enhance Your Background Report that People are Viewing.


NO
See public background info on  Mark 
See Background Report to Learn  the Truth about Mark .











×





Thank you. We received your vote.











×






GET AN ADDITIONAL PREMIUM REPORT ON Mark Carbeau
Premium data contains highly sensitive  info such as:

Arrest Records
Wealth & Assets
Lawsuits & Liens
Licenses & Permits
Sexual Offenses
Corp. Affiliations




                            In order to access the sensitive info on a Premium Report today, an additional fee is required. Remember, you do not need to purchase a Premium Report to access the info that is available in Standard Reports.
                        
BUY PREMIUM REPORT FOR  
No, thank you




THANK YOU FOR YOUR PURCHASE
Your Premium Report is now Ready
CLICK HERE TO SEE REPORT




There is a problem authorizing your charge on this card. Please try your card again or try another card.























Credit Card No.






Expiry Date

MM
01
02
03
04
05
06
07
08
09
10
11
12


Year

                                                        2017

                                                        2018

                                                        2019

                                                        2020

                                                        2021

                                                        2022

                                                        2023

                                                        2024

                                                        2025

                                                        2026

                                                        2027

                                                        2028

                                                        2029

                                                        2030

                                                        2031

                                                        2032

                                                        2033




CVC 









BUY PREMIUM REPORT FOR  
















×
You now have access to view Mark Carbeau's Premium Background Report.

The information in this report is gathered from Government, Social & Public Records gathered from across the web.

                                    Access Mark's Premium Background Report
                                    









×
MyLife Protects & Builds Your Reputation


MyLife gathers up-to-date Government, Social & Public Records so you know what's public everywhere online and help you build your reputation for employers, friends and others that search for you here and on Google.
We recommended you:

Edit & Correct Your Background Report
Complete Your Profile Providing Positive Details
Ask Friends for Positive Reviews
See Who's Checking Your Background
Remove Unwanted Records You Can't Control










×
Review posted! Register to get reply alerts



New to MyLife? Register today for FREE.

Already a member?  Log in







































Name




Email

We respect your privacy


Message


Register to send your email

Gender

                                I am
                                Male
Female



Birthday


MM
01
02
03
04
05
06
07
08
09
10
11
12




DD




YYYY


Must be 13 years or older to join


ZIP Code



Password



Confirm Password




FIND MY PAGE

By clicking on the button above, you agree to our User Agreement & Privacy Policy




See & Monitor All Background Info That's Public On AnyoneWe'll show you all background information, personal reviews and other details from government records and proprietary sources across the web, plus alert you to changes.
Edit and Add-To Your Background Info, Personal Reviews and Social PostsControl your public details to look good to employers, clients, friends and anyone who finds you online.
Send Messages To Get In Touch With AnyoneGet complete contact info on anyone. Send unlimited messages to make valuable professional and personal contacts.












×





Sign up for FREE. See detailed background info for Mark Carbeau











































                                        Already a member? Log in

























VIEW FULL DETAILS




                                       By clicking on the button above, you agree to our User Agreement &  Privacy Policy




*Must be 13 years or older to join






Monitor Your Personal Info & Background Report that's Public Make sure it's accurate.
Edit Your Background Info & Personal ReviewsViewed by employers, clients, friends, or anyone
See Who's Searching for You ® Employers, friends, lovers, stalkers and others are looking for you.
Remove Private Information that's Exposed Stop sites from selling your private details online.
Send Message to Anyone Get complete contact info on anyone, make valuable professional and personal contacts.


Send Message to Anyone Get complete contact info on anyone, make valuable professional and personal contacts.
Monitor Your Personal Info & Background Report that's Public Make sure it's accurate.
Edit Your Background Info & Personal ReviewsViewed by employers, clients, friends, or anyone
See Who's Searching for You ® Employers, friends, lovers, stalkers and others are looking for you.
Remove Private Information that's Exposed Stop sites from selling your private details online.












�
Send a message to  Mark



Compose your message





































Your name




From



Message




SEND YOUR MESSAGE

By clicking on the button above, you agree to our User Agreement & Privacy Policy









×





Sign up for FREE. See detailed background info for Mark Carbeau











































                                        Already a member? Log in

























VIEW FULL DETAILS




                                       By clicking on the button above, you agree to our User Agreement &  Privacy Policy




*Must be 13 years or older to join






Monitor Your Personal Info & Background Report that's Public Make sure it's accurate.
Edit Your Background Info & Personal ReviewsViewed by employers, clients, friends, or anyone
See Who's Searching for You ® Employers, friends, lovers, stalkers and others are looking for you.
Remove Private Information that's Exposed Stop sites from selling your private details online.
Send Message to Anyone Get complete contact info on anyone, make valuable professional and personal contacts.


Send Message to Anyone Get complete contact info on anyone, make valuable professional and personal contacts.
Monitor Your Personal Info & Background Report that's Public Make sure it's accurate.
Edit Your Background Info & Personal ReviewsViewed by employers, clients, friends, or anyone
See Who's Searching for You ® Employers, friends, lovers, stalkers and others are looking for you.
Remove Private Information that's Exposed Stop sites from selling your private details online.












Find Anyone:

Find Anyone:
A|
B|
C|
D|
E|
F|
G|
H|
I|
J|
K|
L|
M|
N|
O|
P|
Q|
R|
S|
T|
U|
V|
W|
X|
Y|
Z







COMPANY
About Us
Testimonials
Press
Careers
Contact Us
Blog
FAQs




SERVICES
Monitor Your Identity
Remove Your Public Profiles
Background Check
See Who's Searching for You
Connect with Friends & Find People
Manage Your Membership




DIRECTORIES
People Search




Visit us on:












                Copyright © Mon Jul 24 22:20:08 PDT 2017 MyLife.com®, Inc. |
User Agreement |
Privacy Policy
U.S. Patent No. 6,701,348 and 6,694,353








	            * The other websites referenced on this site are owned and operated by their respective companies, and the associated trademarks and logos are the property of those companies. Links are provided for reference only and MyLife.com® does not imply any connection or relationship between MyLife.com® and these companies.
	        



 


















Interleukin Genetics Appoints Mark B. Carbeau as CEO - Oral Health Group











































 

 




































×
Subscribe





Home
News
Features
Product Spotlight
Classifieds
Photo Gallery
Continuing Education
Videos
Events
 
Blogs
Digital Archives
Contacts
Advertise
 

Topics


Anesthesiology
Cosmetic / Aesthetic
Dental CAD/CAM
Dental Hygiene
Dental Laboratories
Dental Office
Dental Technology
Dentistry
 

Endodontics
General Practice
Geriatric Dentistry
Health & Healing
Implantology
Materials & Technology
Oral & Systemic Health
Oral Health
 

Oral Surgery
Orthodontics
Periodontics
Prosthodontics
Public Health
 



Magazines 

 View Print Edition


 View Digital Edition


 View Digital Edition


 View Digital Edition
































News
				
				Interleukin Genetics Appoints Mark B. Carbeau as CEO							
			






							April 9, 2015 

							by Interleukin Genetics, Inc.




Topics

Dentistry
General Practice
Oral Health




More News


 


Interleukin Genetics, Inc. (OTCQB: ILIU) today announced the appointment of Mark B. Carbeau as Chief Executive Officer and Director. Dr. Kenneth S. Kornman, DDS, PhD, who served as the President and CEO since August 2012, will continue to serve as President, Chief Scientific Officer and a Director.
Mr. Carbeau is a transformative healthcare leader who brings to Interleukin more than three decades of business expertise in the life science industries, with a proven track record of building high growth diagnostic and pharmaceutical businesses. Recognized as a visionary entrepreneur, Mr. Carbeau has refined or reinvented corporate strategies and business models to maximize the growth potential of multiple companies. His appointment strengthens the executive leadership team and adds significant commercial and operational expertise. 
“On behalf of the Board of Directors of Interleukin Genetics, I am excited to welcome Mark Carbeau to the Company,” said James M. Weaver, Chairman of The Board of Interleukin Genetics. “Mark is a leader with an outstanding track record of building high growth healthcare businesses, including taking multiple products from ideation to commercialization and category leadership. I am confident that under Mark’s leadership the Company will continue to grow and create value for our partners and shareholders.”
Mr. Weaver continued, “I would like to thank Ken for his years of service in the roles of President and CEO. As one of the founders and Chief Scientific Officer of Interleukin, Ken has made many outstanding contributions to the Company, and has been an outspoken proponent of personalized medicine and an industry leader in the research, development and commercialization of genetics-based risk assessment products and services to improve healthcare. We look forward to benefiting from his continued scientific leadership.”
To continue reading, please visit: http://ilgenetics.com/interleukin-genetics-appoints-mark-b-carbeau-as-ceo/.




 Print this page

Tweet

 



Related



 					
						Genetic Risk Assessment for Periodontal Disease Highlighted during American Dental Association Annual Meeting					


 					
						ADA Conference on Genetics in Dentistry					


 					
						Clinical Study Supporting PerioPredict Receives Prestigious Clinical Research Award from the American Academy of Periodontology					


 					
						Mark Bartold receives the 2014 IADR/Straumann Award in Regenerative Periodontal Medicine					






Have your say: Cancel reply 
Your email address will not be published. Required fields are marked *Name *
E-mail *
Website
 

 


 
 
 


 





Classifieds
London, ONA FEMALE ASSOCIATE WITH AT LEAST 3 YEARS EXPERIENCE NEEDED – LONDON,ONNorth Scarborough, ONLOOKING FOR A FT/PT DENTAL ASSOCIATE – NORTH SCARBOROUGH, ONToronto, ONPEDIATRIC DENTIST WANTED – TORONTO, ON
More Classifieds
 





Sponsored Videos

STATIM 5000 from SciCan at PDC 2017
Editorial Videos
Clinical Brief: Cosmetic Bonding Tips





 Henry Schein Named To Forbes’ Debut List Of “America’s Best Employers”
CEREC 30th Anniversary Celebration Entertainment-Only and VIP Packages Selling Out 

 






































Mark B. Carbeau, MBA - Biography

















































































Log in






E-mail



Password







Remember




Forgot password ?









Become a member for free
Sign up





Sign up




New memberSign up for FREE


New customerDiscover our portfolios












 United States
 United Kingdom
 France
 Deutschland
 Schweiz (DE)
 Suisse (FR)










Settings

            Dynamic quotes 


OFFON

















Markets
Equities
North AmericaEuropeAsiaOceaniaMiddle East� More Equities

Indexes
DOW JONESS&P 500NASDAQ 100TSX COMPFTSE 100� More Indexes

Currency / Forex
EUR / USDGBP / USDUSD / JPYUSD / CADAUD / USD� More Currencies

Commodities
GOLDCrude Oil (WTI)Crude Oil (BRENT)SILVERPLATINUM� More Commodities


 News
Latest News
CompaniesMarketsEconomyCurrency / ForexCommoditiesInterest RatesBusiness LeadersFinancial calendarEconomic calendar

Listed company
Analyst reco.RumorsIPOsCapital Markets TransactionsNew ContractsProfits warningsAppointmentsPress ReleasesEventsCorporate actions

Sector News
EnergyBasic MaterialsIndustrialsConsumer CyclicalConsumer Non-CyclicalFinancialsHealthcareTechnologyTelecommunications ServicesUtilities


 Analysis
All AnalysisCommentariesIndex AnalysisStock Trading StrategiesCommodity AnalysisForex Analysis

 Stock Picks
All stock picks

 Portfolios
My Portfolio
Virtual portfolios
4-Traders Portfolios
European PortfolioUSA PortfolioAsian Portfolio


 Screeners
Market Screener HomeFundamental Analyse
Top Investor RatingTop Trading RatingTop ConsensusGrowth stocksYield stocksLow valuations

Technical Analysis
Oversold stocksOverbought stocksClose to resistancesClose to supportsAccumulation phaseMost volatile stocks


 Watchlists
My Watchlists
Watchlists
Top Lists
Yield stocksGrowth stocksUndervalued Stocks


 Top / Flop
Top News
Most Read NewsHot News

Top Fundamentals
Top CapitalizationTop YieldTop PERTop ConsensusTop Fundamentals

Top Technicals
Top RSIUnusual volumesTop GapsTop STIM

Top Movers
Top USATop CanadaTop U.K.Top GermanyTop EuropeTop Asia


 Tools
Market ScreenerDynamic chartFinancial calendarEconomic calendarSector researchCurrency converter

 Our Services
Premium AccessDiscover our Services

 



















 






4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography


Business Leaders




Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors HomeAll newsMost read newsBusiness Leaders Biography


 
















Mark B. Carbeau, MBA

Age : 56Public asset : 5,835 USDLinked companies :  Interleukin Genetics, Inc 





Summary 



Mr. Mark B. Carbeau is Chief Executive Officer & Director at Interleukin Genetics, Inc.He is on the Board of Directors at Interleukin Genetics, Inc.Mr. Carbeau was previously employed as Chairman & Chief Executive Officer by PolyRemedy, Inc., President & Chief Executive Officer by HyperMed, Inc., President-USA Division by Kinetic Concepts, Inc., Chief Executive Officer by Diagnostyx, Inc., Founder by CM Partners, a Manager by The Boston Consulting Group, Inc., Marketing Officer by Eli Lilly & Co., and Vice President-Corporate Development by OraPharma, Inc.He received his undergraduate degree from Pennsylvania State University and an MBA from The Wharton School of the University of Pennsylvania.



Current positions of Mark B. Carbeau, MBA 









 NameTitle
Since
 Interleukin Genetics, Inc(Healthcare Facilities & Services)
Chief Executive Officer & Director
2015



Holdings of Mark B. Carbeau, MBA 










 NameEquities%Valuation

 Interleukin Genetics, Inc (ILIU) Healthcare Facilities & Services 100,6030.044%5,835 USD



Mark B. Carbeau, MBA: Personal Network 







 NameLinked companies

Stephen J. DiPalma Interleukin Genetics, Inc 

James M. Weaver Interleukin Genetics, Inc 

William C. Mills Interleukin Genetics, Inc 

Kenneth S. Kornman Interleukin Genetics, Inc 

Dayton Misfeldt Interleukin Genetics, Inc 

Lionel Carnot Interleukin Genetics, Inc 

Joseph M. Landstra Interleukin Genetics, Inc 

Stephan Toutain Interleukin Genetics, Inc 

Mary Hiter Interleukin Genetics, Inc 

Gary L. Crocker Interleukin Genetics, Inc 




Most Read News 




07/18DJMARK LIGHT : Top Company News of the Day



07/18DJNELSON PELTZ : Peltz Goes on Offense In Break From Form -- WSJ



07/18DJCHARLES SCHWAB : U.S. Stocks Set To Open A Little Higher, Helped By Netflix's Jump



07/19 JAMIE DIMON : JPMorgan's Jamie Dimon lashes out against Washington politics



07/19 DAVID HENRY : JPMorgan posts higher profit; shares dip on net interest income view



07/18 DAVID HENRY : U.S. banks pay up for big deposits as consumers get pennies



07/19DJJAMES MURDOCH : Top Energy News of the Day



07/19 RUPERT MURDOCH : Murdochs warn UK a delay to Sky-Fox deal could hit inward investment



07/19 PHILIP GREEN : Philip Green poaches Burberry man to be TopShop CEO



07/20 THOMAS WILSON : Most Japanese companies look to raise retirement age - Reuters poll



More news

 


            © 2017 People and Ownership :    









Advertisement








Mark B. Carbeau, MBA : Connections 



 Merus NV









Lionel Carnot




 Interleukin Genetics, Inc









Stephen J. DiPalmaJames M. WeaverWilliam C. MillsKenneth S. KornmanDayton MisfeldtLionel CarnotJoseph M. LandstraStephan ToutainMary Hiter




 Sunesis Pharmaceuticals, Inc.









Dayton Misfeldt




 Merrimack Pharmaceuticals Inc









Gary L. Crocker




Rejuvenation Labs, Inc.
                                            








Gary L. Crocker





Earlybird Venture Capital GmbH & Co. KG
                                            








Lionel Carnot





Product Development & Management Association
                                            








James M. Weaver





Design Management Institute
                                            








James M. Weaver





Sorenson Legacy Foundation
                                            








Gary L. Crocker





Alticor Corp.
                                            








James M. WeaverJoseph M. Landstra





The American Marketing Association
                                            








James M. Weaver





Ascension Health Ventures III LLC
                                            








William C. Mills





Encycle Therapeutics, Inc.
                                            








William C. Mills





Utah Technology Council
                                            








Gary L. Crocker





Gurwitch UK Ltd.
                                            








Joseph M. Landstra





Danforth Advisors LLC
                                            








Stephen J. DiPalma





Gurwitch Products LLC
                                            








Joseph M. Landstra





Alticor Corporate Enterprises
                                            








Joseph M. Landstra





Aciex Therapeutics, Inc.
                                            








Dayton Misfeldt





Metagenics, Inc.
                                            








Joseph M. Landstra





 







Popular Business Leaders 


 

Bernard Arnault
Mary Barra
Lloyd Blankfein
Michael Bloomberg
Yannick Bollor�
Warren Buffett
Antony Burgmans
Jean-paul Clozel
Gary Cohn
Jamie Dimon
Ralph Dommermuth
Sebastian Ebel
John Edwards
David Einhorn
Jeff Fettig
Mark Fields
Carlos Ghosn
Terry Gou
David Henry
Carl Icahn
R. Johnson
Michel Landel
Daniel Loeb
Jack Ma
John Mackey
Marissa Mayer
Lakshmi Mittal
Rupert Murdoch
Elon Musk
Peter Nicholas
John Paulson
Nelson Peltz
Georges Plassat
Hasso Plattner
Thomas Rabe
Giuseppe Recchi
Wolfgang Reitzle
Urs Rohner
Wilbur Ross
Charles Schwab
Igor Sechin
Pascal Soriot
George Soros
Rupert Stadler
Bernard Tapie
John Williamson
Thomas Wilson
Dieter Zetsche
Mark Zuckerberg



A-Z Business Leaders




 



























4-traders.com :MarketsNewsAnalysisStock PicksPortfoliosScreenersWatchlistsTop / FlopToolsOur ServicesAbout :Surperformance SASContact usAdvertiseLegal informationsAbout usStay Connected :FacebookTwitterPartners :B�rse: Aktien, Kurse und NachrichtenBest tweets 




   Copyright � 2017 Surperformance. All rights reserved.  












 














Slave





